Supernus SUPN
NASDAQ SUPN
$29.17 +0.42 (+1.46%)
As of: Nov 11, 2026 · 11:50 AM EST

Supernus (SUPN) Price to Book (2021 - 2023)

Updated

Supernus Pharmaceuticals' (SUPN) Price to Book was 2.36 for Q3 2026, down 9.3% from 2.60 a year earlier and down 10.0% from the prior quarter.

Analysis

Supernus (SUPN) Price to Book (2021 - 2023) Analysis & Trends

For FY2025, Price to Book at Supernus Pharmaceuticals was 2.69, up 38.2% from FY2024.

  • By year, Price to Book came in at 1.95 in FY2024 (+13.2%), 1.72 in FY2023 (-21.3%), 2.18 in FY2022 (+14.7%) and 1.90 in FY2021 (+6.6%).
  • The Q3 2026 figure ranks as the lowest quarterly Price to Book since Q2 2025.
  • Year over year, Price to Book gained in six of the last eight quarters, with growth averaging 25.7%.
  • The high point for year-over-year Price to Book in five years was Q2 2026 (growth of 57.8%); the low point was Q3 2023 (a decline of 22.4%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at 2.62 (Q2 2026), 2.79 (Q1 2026) and 2.69 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Supernus 3.39 Bn 2.50 Bn 305.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 35.07
Sep 30, 2022 3.30
Jun 30, 2022 2.84
Dec 31, 2021 35.10
API Access

Supernus Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=SUPN&period=max&api_key=YOUR_API_KEY